Curated News
By: NewsRamp Editorial Staff
July 16, 2026
Private Label CBD Gummies Market to Hit $1.38B by 2036
TLDR
- Private label CBD gummies offer wellness brands a fast, low-cost market entry without investing in manufacturing infrastructure.
- White label gummies dominate with 46.2% share, using ready-made formulations to speed up product launches.
- Broad-spectrum THC-free gummies meet consumer demand for safe, transparent wellness products, improving trust and access.
- The US leads growth at 8.5% CAGR as direct-to-consumer brands leverage digital channels and subscription models.
Impact - Why it Matters
For wellness brands and investors, the private label CBD gummies market presents a strategic opportunity to enter the booming CBD edibles segment with reduced risk and faster time-to-market. As consumer demand for THC-free, clean-label products grows, companies that leverage white label manufacturing can focus on branding and customer acquisition rather than production. However, navigating regulatory complexities and ensuring compliance will be critical for success. This market's expansion signals a shift toward outsourced, scalable production models that could reshape the broader functional wellness industry.
Summary
The Private Label CBD Gummies Market is poised for significant growth, according to a new report from Future Market Insights (FMI). Valued at USD 598.9 million in 2025, the market is projected to reach USD 646.2 million in 2026 and soar to USD 1,382.2 million by 2036, expanding at a robust CAGR of 7.9%. This surge is driven by wellness brands increasingly turning to outsourced manufacturing to reduce capital investment and accelerate product launches. White Label Gummies dominate the service model segment with a 46.2% share in 2026, while Broad-Spectrum CBD Gummies lead the spectrum category at 42.8%. Brand Websites are the top sales channel, accounting for 39.6% of demand, and the United States is the fastest-growing market with an 8.5% CAGR through 2036.
Key players such as CBD Nationwide, Extract Labs, cbdMD, Inc., Charlotte’s Web Holdings, Inc., and CV Sciences, Inc. are competing on formulation expertise, manufacturing scalability, and compliance support. The report highlights that private label manufacturing allows companies to enter the market quickly without investing in extraction facilities or confectionery infrastructure. Retailers and regulators are emphasizing batch testing, ingredient traceability, and labeling accuracy, pushing manufacturers to enhance quality assurance. Nandini Roy Choudhury, Principal Consultant at FMI, notes that competitive advantage will hinge on suppliers offering comprehensive testing, compliant labeling, and retail-ready documentation.
The market faces regulatory complexities across countries, which can delay commercialization and increase costs. However, trends such as THC-free formulations, customized gummies for sleep and relaxation, third-party testing, sustainable packaging, and subscription-based direct-to-consumer models are accelerating growth. The United States, Canada, and the United Kingdom are among the fastest-growing countries. FMI’s report provides detailed insights into service models, CBD spectrum, dosage strength, sales channels, and regional dynamics, offering a roadmap for stakeholders navigating this evolving landscape.
Source Statement
This curated news summary relied on content disributed by 24-7 Press Release. Read the original source here, Private Label CBD Gummies Market to Hit $1.38B by 2036
